Скачать или смотреть Enhance Productivity and Purity in Next-generation Bispecific Antibody Manufacturing

Bispecific antibodies (BsAbs) hold great promise in next-generation therapies, but manufacturing them at scale remains complex. From secretion inefficiencies to chain mispairing and impurity accumulation, these challenges can hinder progress from research to clinical development.

In this webinar, Dr. Heng Tai Liew, Senior Protein Scientist at GenScript, introduces how TurboCHO™, GenScript’s proprietary expression platform, addresses these critical bottlenecks. Learn how an integrated, iterative workflow—powered by Design of Experiments (DOE) and advanced chromatography purification—enhances yields, purity, and scalability of BsAb production.

What you’ll learn:
🎯 Key challenges in bispecific antibody development and why they matter
🎯 How GenScript’s TurboCHO™ system optimizes expression through vector, media, and cell line engineering
🎯 Strategies for overcoming chain mispairing and maximizing secretion efficiency
🎯 Advanced purification methods tailored for selective impurity removal
🎯 Real-world case studies demonstrating success across multiple BsAb formats

Ideal for researchers, process development scientists, and therapeutic developers focused on accelerating bispecific antibody programs from bench to clinic.

Learn more about TurboCHO™: https://www.genscript.com/transient-e...